There are no classic withdrawal effects in the way we think of for drugs like steroids, opioids, or benzodiazepines when voriconazole is stopped. However, some patients do experience transient symptoms or rebound effects, especially if the drug was managing an active infection or inflammation.
Here’s what you should know:
✅ What Usually Happens When Voriconazole Is Stopped?
1. No physiological withdrawal syndrome
-
Voriconazole does not cause dependence or withdrawal at a chemical level.
-
You don’t need to taper it for pharmacological reasons — it can generally be stopped abruptly.
⚠️ But Some Symptoms May Still Appear
These aren’t “withdrawal” symptoms in the classical sense, but can occur:
A. Return of underlying symptoms
-
If the aspergillosis was only partially controlled, symptoms like cough, chest pain, or fatigue may recur.
-
Especially in CPA or ABPA, stopping antifungals too soon can cause flare-ups.
B. Immune rebound
-
Very rarely, immune reconstitution reactions (like in ABPA or after neutropenia) may occur as the immune system re-engages with fungal antigens.
-
This is not true withdrawal, but a host response shift.
C. Psychological or sensory changes
-
Some patients who had visual disturbances or strange dreams while on voriconazole report a brief “readjustment” period after stopping (often relief, but occasionally some lingering discomfort).
-
These effects usually resolve quickly.
👩⚕️ What To Watch For After Stopping
| Symptom | Likely Cause | What to Do |
|---|---|---|
| Return of cough, sputum, fatigue | Infection flaring again | Recheck IgE, CRP, imaging, sputum |
| Headache, dizziness | Rarely linked to stopping, more likely underlying illness or fatigue | Monitor; seek review if worsening |
| Mood shifts, anxiety | Possibly related to underlying illness stress, or stopping long-term meds | Supportive care, discuss with clinician |
🧾 Summary
-
No true withdrawal syndrome with voriconazole
-
Symptoms that return are usually related to underlying disease or immune changes
-
Best to stop under specialist advice, ideally with a plan for monitoring over 2–6 weeks
Share this post
Latest News posts
Fungal vaccine developments
March 22, 2023
Asthma UK’s End the Lung Health Lottery
March 21, 2023
Secondary Adrenal Insufficiency
March 17, 2023
IgG and IgE explained
March 14, 2023
Spring COVID Booster
March 8, 2023
Accessing GP services
March 8, 2023
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
